Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

NCT: NCT03507205 · COMPLETED

NCT IDNCT03507205
StatusCOMPLETED
Start Date2008-04-01
Completion2017-11-30

Brief Summary

The objective of this study is to evaluate the long-term efficacy and safety of coronary stenting with the various types of drug-eluting stents (DES) and to determine clinical device and procedural success during commercial use of DES in the real world. The investigators will compare EES (Xience V/Promus and Xience Prime), SES (Cypher), ZES (Resolute Integrity, Endeavor Resolute, Endeavor), and BES (Biomatrix, Biomatrix Flex, and Nobori).

Frequently Asked Questions

What is Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents?

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents is a clinical trial registered under NCT03507205. Current status: COMPLETED.

What is the status of NCT03507205?

The current status of NCT03507205 (Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents) is: COMPLETED.

When did Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents start?

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents started on 2008-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.